Due to current COVID-19 restrictions and following on from the success of last year’s virtual London Calling conference, the upcoming London Calling 2021 is also going ahead online. Ki...

Mobile COVID-19 testing laboratories containing Oxford Nanopore’s LamPORE test are now being deployed in a pilot programme, to support testing efforts, including in remote locations. The...

Oxford Nanopore Technologies and NVIDIA are collaborating this year to integrate the NVIDIA DGX Station A100 into Oxford Nanopore’s ultra-high throughput sequencing system, PromethION. P...

Dear all, As each year draws to an end, we reflect on its highlights. You can read our 2019 and 2018 blogs here. But 2020 was a year like no other; it's hard to think of the following as...

Oxford, 21st December 2020. A study of more than 23,000 samples carried out by teams across the UK shows Oxford Nanopore’s COVID-19 test, LamPORE, is highly accurate for the detection of...

Oxford Nanopore’s rapid LamPORE COVID-19 test to be made available via SourceBio accredited lab facilities. Oxford Nanopore Technologies Limited (“Oxford Nanopore”), a leading next gene...

During an update at the 2020 Nanopore Community Meeting, Oxford Nanopore revealed a number of key advances in its sequencing technology. These include the release of new improvements in ...

Two new papers published in Nature Biotech today, from teams at the University of Nottingham and Johns Hopkins University, demonstrate the use of real-time nanopore sequencing and adaptiv...

Today marks the release of the MinKNOW App for iOS and Android devices, now available to download from the Apple Store and Google Play. MinKNOW is the operating software that drives nano...

Somatic mutations are the driving force behind cancer development, and structural variations (SVs) are more and more being recognised as an important class of these mutations. The detecti...

Adam Ewing leads the Translational Bioinformatics Group at the Mater Research Institute - University of Queensland in Australia, where he works to develop methods and software for analy...

The significance of structural variation in human genomics is becoming increasingly established in many fields, from cancer to neurology and the mechanisms of rare disease. With research ...

This week we heard from Ariel Gershman, Shruti Iyer and Tuuli Lappalainen on their latest research addressing some of the key challenges in human genomics using nanopore technology. The t...

- announced at the 2020 American Society of Human Genetics (ASHG) Meeting. Oxford, UK, 28th October 2020. Oxford Nanopore announces multiple releases that expand and improve its sequen...

ASHG 2020 has moved online this year but there’s still plenty going on and lots of ways you can find out about how human genomics researchers are overcoming some of the big challenges i...

In this blog, Tao Jiang describes his work on the development of the structural variant (SV) caller cuteSV. Read on to find out how the cuteSV bioinformatics pipeline works, how it perfor...

Oxford, UK: Oxford Nanopore Technologies has raised £84.4M in new capital. The funding comes from existing investors and new investors, including International Holdings Company (IHC), R...

Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Afri...

LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a pa...

Accurate molecular diagnosis of cancer-causing germline variants enables increased screening, early detection, prevention, and optimal treatment, if cancer does arise in predisposed pat...

Guy has extensive experience in healthcare and technology investment and entrepreneurship. He was previously on the leadership team at Harel Insurance Investments and Financial Services, ...

In this blog, Filippo Martignano shares his research into copy number variation (CNV) analysis in cancer, from cell-free DNA samples, using shallow whole-genome sequencing. Read on to hea...

Scientists from the University of Oxford’s Nuffield Department of Medicine, Public Health England Porton Down (PHE), the University of Sheffield, Sheffield Teaching Hospitals NHS Foundati...

New Cas9 Sequencing Kit provides reagents for one-stop targeted sequencing, enabling scientists to cost-effectively sequence previously inaccessible target regions. Cas9 targeted sequ...